Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basket Study of Brigatinib in ROS1-Rearranged Advanced Solid Tumors
jRCT2080224774Phase 2Completed
- Sponsor
- National Cancer Center Hospital East
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of brigatinib in Nonhematologic neoplasms, sponsored by National Cancer Center Hospital East. Started Jul 2019; status: completed.
02
Drugs
brigatinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080224774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224774.